ZEKE CAPITAL ADVISORS, LLC - INHIBIKASE THERAPEUTICS INC ownership

INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 6 filers reported holding INHIBIKASE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ZEKE CAPITAL ADVISORS, LLC ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$46,900
-44.8%
93,8000.0%0.00%
-50.0%
Q3 2022$85,000
+21.4%
93,8000.0%0.01%
+20.0%
Q2 2022$70,000
-49.6%
93,8000.0%0.01%
-28.6%
Q1 2022$139,000
+0.7%
93,8000.0%0.01%
-12.5%
Q4 2021$138,000
-22.5%
93,8000.0%0.01%
-20.0%
Q3 2021$178,000
-32.3%
93,8000.0%0.01%
-41.2%
Q2 2021$263,000
+132.7%
93,800
+398.9%
0.02%
+112.5%
Q1 2021$113,000
-13.1%
18,8000.0%0.01%
-27.3%
Q4 2020$130,00018,8000.01%
Other shareholders
INHIBIKASE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 937,500$696,0000.97%
HAMILTON LANE ADVISORS LLC 165,635$123,0000.05%
Redmond Asset Management, LLC 122,682$91,0000.03%
Retirement Planning Co of New England, Inc. 64,606$47,0000.03%
Antara Capital LP 403,000$299,0000.01%
ZEKE CAPITAL ADVISORS, LLC 93,800$70,0000.01%
Koshinski Asset Management, Inc. 65,377$49,0000.01%
K.J. Harrison & Partners Inc 18,300$14,0000.00%
Warberg Asset Management LLC 14,493$11,0000.00%
Shay Capital LLC 10,708$8,0000.00%
View complete list of INHIBIKASE THERAPEUTICS INC shareholders